Congressional Research Service Reports - 20 Matching Results
Search Results
- Mexican Drug Certification Issues: U.S. Congressional Action, 1986-1998
- No Description Available.
- No-fault Eviction of Public Housing Tenants for Illegal Drug Use: A Legal Analysis of Department of Housing and Urban Development v. Rucker
- No Description Available.
- The Safe and Drug-Free Schools and Communities Program: Background and Context
- Congressional Research Service (CRS) report entailing information about the context and background of the Safe and Drug-Free schools and Communities Program. Topics include, impact evaluation, the national coordinator program, grants to reduce alcohol abuse etc..
- Drug Certification Requirements and Congressional Modifications in 2001-2002
- This report provides a brief summary of the existing drug certification requirements for drug producing and drug-transit countries, background on the experience, criticisms, and reform efforts under these provisions; a summary of early congressional options and proposals advanced in 2001, with possible advantages and disadvantages; a summary of later initiatives with legislative activity; and (5) a tracking of legislative action on the major initiatives.
- War on Drugs: Legislation in the 108th Congress and Related Developments
- No Description Available.
- Drug Control: International Policy and Approaches
- Over the past decade, worldwide production of illicit drugs has risen dramatically: opium and marijuana production has roughly doubled and coca production tripled. Street prices of cocaine and heroin have fallen significantly in the past 20 years, reflecting increased availability. Despite apparent national political resolve to deal with the drug problem, inherent contradictions regularly appear between U.S. anti-drug policy and other national policy goals and concerns. The mix of competing domestic and international pressures and priorities has produced an ongoing series of disputes within and between the legislative and executive branches concerning U.S. international drug policy. One contentious issue has been the Congressionally-mandated certification process, an instrument designed to induce specified drug-exporting countries to prioritize or pay more attention to the fight against narcotics businesses.
- War on Drugs: Legislation in the 108th Congress and Related Developments
- No Description Available.
- Illicit Drugs and the Terrorist Threat: Causal Links and Implications for Domestic Drug Control Policy
- The international traffic in illicit drugs contributes to terrorist risk through at least five mechanisms: supplying cash, creating chaos and instability, supporting corruption, providing “cover” and sustaining common infrastructures for illicit activity, and competing for law enforcement and intelligence attention. Of these, cash and chaos are likely to be the two most important.
- Sentencing Under the Federal Sentencing Guidelines: An Abridged Controlled Substance Example
- No Description Available.
- Drug Control: International Policy and Approaches
- Over the past decade, worldwide production of illicit drugs has risen dramatically: opium and marijuana production has roughly doubled and coca production tripled. Street prices of cocaine and heroin have fallen significantly in the past 20 years, reflecting increased availability. Despite apparent national political resolve to deal with the drug problem, inherent contradictions regularly appear between U.S. anti-drug policy and other national policy goals and concerns. The mix of competing domestic and international pressures and priorities has produced an ongoing series of disputes within and between the legislative and executive branches concerning U.S. international drug policy. One contentious issue has been the Congressionally-mandated certification process, an instrument designed to induce specified drug-exporting countries to prioritize or pay more attention to the fight against narcotics businesses.
- War on Drugs: Reauthorization of the Office of National Drug Control Policy
- This report discusses the Office of National Drug Control Policy Reauthorization Act of 2005 , which would reauthorize ONDCP for five years, through FY2010, and authorize funding in specific annual amounts for the High Intensity Drug Trafficking Area (HIDTA) Program, the media campaign, a Southwest Border violence study, and several anti-methamphetamine initiatives.
- Andean Counterdrug Initiative (ACI) and Related Funding Programs: FY2007 Assistance
- This report discusses the funds and material support the U.S. has contributed to help Colombia and the Andean region fight drug trafficking since the development of Plan Colombia in 1999.
- Afghanistan: Narcotics and U.S. Policy
- This report provides current statistical information, profiles the Afghanistan narcotics trade's participants, explores linkages between narcotics, insecurity, and corruption, and reviews U.S. and international policy responses since late 2001. The report also considers ongoing policy debates regarding the counternarcotics role of coalition military forces, poppy eradication, alternative livelihoods, and funding issues for Congress.
- ATPA Renewal: Background and Issues
- This report outlines the various aspects of the Andean Trade Preference Act (ATPA), including significant dates and modifications. The ATPA extends special duty treatment to certain U.S. imports from Bolivia, Colombia, Ecuador, and Peru that meet domestic content and other requirements. The purpose of ATPA is to promote economic growth in the Andean region and to encourage a shift away from dependence on illegal drugs by supporting legitimate economic activities.
- U.S.-Mexican Security Cooperation: The Mérida Initiative and Beyond
- This report provides a framework for examining the current status and future prospects for U.S.- Mexican security cooperation. It begins with a brief discussion of the threat that drug trafficking and related crime and violence pose to both nations, followed by an analysis of the evolution of the Mérida Initiative. The report then provides an overview of the Peña Nieto government's security strategy and how it is affecting the Mérida Initiative. The report then examines key aspects of the current U.S.-Mexican security strategy and concludes by raising policy issues that may affect bilateral efforts.
- Marijuana: Medical and Retail-- Selected Legal Issues
- This report discusses the federal Controlled Substances Act (CSA) as it pertains to marijuana. The CSA outlaws the possession, cultivation, and distribution of marijuana except for authorized research. More than 20 states have regulatory schemes that allow possession, cultivation, and distribution of marijuana for medicinal purposes. The U.S. Constitution's Supremacy Clause preempts any state law that conflicts with federal law.
- The World Drug Problem: UNGA Convenes for a Special Session
- This report briefly discusses the United Nations General Assembly (UNGA), which has convened in New York for a special session on "The World Drug Problem." It is the third time the UNGA will convene such a session on global drug issues. Previous special sessions on drugs were held in 1990 and 1998.
- The World Drug Problem: UNGA Convenes for a Special Session
- This report briefly discusses the United Nations General Assembly's (UNGA) 2016 special session on "The World Drug Problem." It is the third time the UNGA will convene such a session on global drug issues.
- The World Drug Problem: UNGA Convenes for a Special Session
- This report discusses the U.N. special session on the problem of drug abuse in the world. The interests and outcomes of the U.S. and U.N are also discussed.
- Legal Authorities Under the Controlled Substances Act to Combat the Opioid Crisis
- This report discusses legal authorities available to the federal government under the Controlled Substances Act (CSA) that could be used to combat the opioid epidemic. The report then examines DEA initiatives and actions taken, pursuant to its legal authorities under the CSA, which specifically target the abuse of opioids. It concludes by discussing selected opioid-related legislative proposals in the 115th Congress that would amend the CSA.